BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23670958)

  • 1. A synthetic anti-inflammatory sterol improves insulin sensitivity in insulin-resistant obese impaired glucose tolerance subjects.
    Reading CL; Stickney DR; Flores-Riveros J; Destiche DA; Ahlem CN; Cefalu WT; Frincke JM
    Obesity (Silver Spring); 2013 Sep; 21(9):E343-9. PubMed ID: 23670958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of glucose intolerance by the synthetic androstene HE3286: link to inflammatory pathways.
    Wang T; Villegas S; Huang Y; White SK; Ahlem C; Lu M; Olefsky JM; Reading C; Frincke JM; Alleva D; Flores-Riveros J
    J Pharmacol Exp Ther; 2010 Apr; 333(1):70-80. PubMed ID: 20068030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects.
    Zhang Y; Han P; Wu N; He B; Lu Y; Li S; Liu Y; Zhao S; Liu L; Li Y
    Obesity (Silver Spring); 2011 Aug; 19(8):1647-53. PubMed ID: 21593803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats.
    Lu M; Patsouris D; Li P; Flores-Riveros J; Frincke JM; Watkins S; Schenk S; Olefsky JM
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1036-48. PubMed ID: 20159859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone improves glucose metabolism in obese adolescents with impaired glucose tolerance: a pilot study.
    Cali AM; Pierpont BM; Taksali SE; Allen K; Shaw MM; Savoye M; Caprio S
    Obesity (Silver Spring); 2011 Jan; 19(1):94-9. PubMed ID: 20467418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
    Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
    J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of glucose, insulin, and C-reactive protein to determine need for glucose tolerance testing.
    Thompson WG; Bergstralh EJ; Slezak JM
    Obes Res; 2003 Aug; 11(8):1027-32. PubMed ID: 12917509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
    Nolan JJ; Ludvik B; Beerdsen P; Joyce M; Olefsky J
    N Engl J Med; 1994 Nov; 331(18):1188-93. PubMed ID: 7935656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load.
    Derosa G; Cicero AF; Fogari E; D'Angelo A; Bonaventura A; Romano D; Maffioli P
    J Clin Lipidol; 2012; 6(6):553-64. PubMed ID: 23312051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An orally bioavailable synthetic analog of an active dehydroepiandrosterone metabolite reduces established disease in rodent models of rheumatoid arthritis.
    Offner H; Firestein GS; Boyle DL; Pieters R; Frincke JM; Garsd A; White SK; Reading CL; Auci DL
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1100-9. PubMed ID: 19297421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.
    Syvertsen C; Halse J; Høivik HO; Gaullier JM; Nurminiemi M; Kristiansen K; Einerhand A; O'Shea M; Gudmundsen O
    Int J Obes (Lond); 2007 Jul; 31(7):1148-54. PubMed ID: 17031391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic characteristics of glucose intolerance: the critical role of obesity.
    Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance.
    Straczkowski M; Kowalska I; Nikolajuk A; Otziomek E; Adamska A; Karolczuk-Zarachowicz M; Gorska M
    Int J Obes (Lond); 2007 Feb; 31(2):221-5. PubMed ID: 16770329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
    Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.